HCA Healthcare (NYSE:HCA) had its price target upped by analysts at Royal Bank of Canada to $117.00 in a report issued on Wednesday. The brokerage presently has an “outperform” rating on the stock. Royal Bank of Canada’s price objective suggests a potential upside of 15.66% from the company’s current price.
A number of other analysts have also issued reports on the company. Credit Suisse Group increased their target price on HCA Healthcare from $115.00 to $122.00 and gave the company an “outperform” rating in a report on Wednesday. Leerink Swann increased their target price on HCA Healthcare from $105.00 to $120.00 and gave the company an “outperform” rating in a report on Wednesday. SunTrust Banks increased their target price on HCA Healthcare to $120.00 and gave the company a “positive” rating in a report on Wednesday. Piper Jaffray Companies restated a “hold” rating and issued a $101.00 target price on shares of HCA Healthcare in a report on Tuesday. Finally, Cantor Fitzgerald restated a “buy” rating and issued a $115.00 target price on shares of HCA Healthcare in a report on Tuesday. Four analysts have rated the stock with a sell rating, five have assigned a hold rating and eighteen have issued a buy rating to the company. HCA Healthcare presently has a consensus rating of “Buy” and an average price target of $99.90.
Shares of HCA Healthcare (NYSE HCA) traded down $0.29 during trading hours on Wednesday, hitting $101.16. The stock had a trading volume of 3,717,452 shares, compared to its average volume of 2,350,000. The firm has a market cap of $36,540.00, a P/E ratio of 17.03, a PEG ratio of 1.27 and a beta of 0.55. HCA Healthcare has a one year low of $71.18 and a one year high of $106.84. The company has a debt-to-equity ratio of -6.46, a current ratio of 1.68 and a quick ratio of 1.41.
In related news, insider Michael S. Cuffe sold 2,150 shares of the stock in a transaction on Wednesday, November 22nd. The stock was sold at an average price of $78.00, for a total transaction of $167,700.00. Following the completion of the sale, the insider now directly owns 12,476 shares in the company, valued at $973,128. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, SVP Joseph A. Sowell III sold 58,175 shares of the stock in a transaction on Friday, January 26th. The stock was sold at an average price of $95.00, for a total value of $5,526,625.00. Following the sale, the senior vice president now owns 40,536 shares of the company’s stock, valued at $3,850,920. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 78,725 shares of company stock valued at $7,132,797. 2.90% of the stock is owned by corporate insiders.
Several large investors have recently made changes to their positions in HCA. Glenview Capital Management LLC increased its position in HCA Healthcare by 2.6% during the second quarter. Glenview Capital Management LLC now owns 14,899,289 shares of the company’s stock worth $1,299,218,000 after buying an additional 384,024 shares during the last quarter. Longview Partners Guernsey LTD increased its position in HCA Healthcare by 22.6% during the third quarter. Longview Partners Guernsey LTD now owns 11,135,155 shares of the company’s stock worth $886,247,000 after buying an additional 2,053,701 shares during the last quarter. APG Asset Management N.V. increased its position in HCA Healthcare by 6.3% during the fourth quarter. APG Asset Management N.V. now owns 3,639,381 shares of the company’s stock worth $266,225,000 after buying an additional 216,000 shares during the last quarter. Arrowstreet Capital Limited Partnership increased its position in HCA Healthcare by 25.1% during the second quarter. Arrowstreet Capital Limited Partnership now owns 2,887,684 shares of the company’s stock worth $251,806,000 after buying an additional 580,084 shares during the last quarter. Finally, American Century Companies Inc. increased its position in HCA Healthcare by 49.5% during the third quarter. American Century Companies Inc. now owns 2,558,216 shares of the company’s stock worth $203,608,000 after buying an additional 847,377 shares during the last quarter. Institutional investors and hedge funds own 75.23% of the company’s stock.
HCA Healthcare Company Profile
HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.
